Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Factors influencing referral to rheumatologist for rheumatoid arthritis

From: Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement

   Likelihood of referring
  Total cohort Very likely Possible Unlikely
  ( n = 266 a ) ( n = 189) ( n = 73) ( n = 4)
Situations leading up to referral     
   Advanced disease 213 (80%) 153 (81%) 60 (82%) 0 (0%)
   Patient desire for a referral 211 (79%) 153 (81%) 54 (74%) 4 (100%)
   Uncomfortable prescribing DMARDs 186 (70%) 152 (80%) 33 (45%) 1 (25%)
   Patient comorbidities 107 (40%) 85 (45%) 20 (27%) 2 (50%)
   Other 14 (5%) 11 (6%) 3 (4%) 0 (0%)
Patients report of difficulty getting rheumatology appointmentb     
   Yes, most of the time 74 (44%) 49 (40%) 25 (57%) 0 (0%)
   No, never 95 (56%) 74 (60%) 19 (43%) 2 (50%)
Main reason for not referring     
   Do not know a rheumatologist 19 (7%) 10 (5%) 9 (12%) 0 (0%)
   Rheumatology appointment too difficult to get 73 (27%) 46 (24%) 27 (37%) 0 (0%)
   No need 63 (24%) 32 (17%) 27 (37%) 4 (100%)
   Insurance problems 107 (40%) 74 (39%) 33 (45%) 0 (0%)
   Other 48 (18%) 37 (20%) 11 (15%) 0 (0%)
  1. aOne missing response. bOne hundred three missing responses because of an error in the electronic survey. DMARD, disease-modifying anti-rheumatic drug.